# Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

> **NCT05478707** · PHASE2 · SUSPENDED · sponsor: **University of Virginia** · enrollment: 47 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Endothelial Dysfunction

## Interventions

- **DRUG:** Dulaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05478707
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-10-05
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-07-30
- **Target enrollment:** 47 (ESTIMATED)
- **Why stopped:** Institution transfer
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478707, "Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05478707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*